Ibudilast: all 21 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Regeneration in Cervical Degenerative MyelopathyRecruitingNCT04631471Phase 3
- Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSCompletedNCT04429555Phase 2Results posted
- Ibudilast for the Treatment of Alcohol Use DisorderCompletedNCT03594435Phase 2Results posted
- Ibudilast and Withdrawal-Related DysphoriaCompletedNCT03489850Phase 2Results posted
- A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)CompletedNCT02714036Phase 1/2Results posted
- Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02238626Phase 2Results posted
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisCompletedNCT01982942Phase 2Results posted
- Trial of Ibudilast for Methamphetamine DependenceCompletedNCT01860807Phase 2Results posted
- Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid WithdrawalCompletedNCT00723177Phase 2Results posted
- RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative MedicineCompletedNCT05513560Phase 2/3
- Ibudilast for Treating Alcohol Use DisorderActive, not recruitingNCT05414240Phase 2
- Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALSActive, not recruitingNCT04057898Phase 2/3
- Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy VolunteersCompletedNCT04054206Phase 1
- Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent GlioblastomaCompletedNCT03782415Phase 1/2
- Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy VolunteersCompletedNCT03533387Phase 1
- Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine UsersCompletedNCT03341078Phase 2
- Development of Ibudilast for Alcohol Use DisorderCompletedNCT02025998Phase 1
- Ibudilast in the Treatment of Patients With Chronic Migraine.CompletedNCT01389193Phase 1
- Ibudilast in the Treatment of Medication Overuse HeadacheStatus unknownNCT01317992Phase 1/2
- Safety Interaction Trial Ibudilast and MethamphetamineCompletedNCT01217970Phase 1
- Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic PainCompletedNCT00576277Phase 1/2